[Beta subunit of human chorionic gonadotropin, CA 125 antigen and CA 19-9 antigen with non-trophoblastic malignancy of genital tract. Vulval cancer].
Our investigations embraced the group of patients with vulval cancer before surgical treatment (n = 10). We measured in serum of blood the level of the total human chorionic gonadotrophin hCG, beta subunit of human Chorionic Gonadotrophin, CA 125 and CA 19-9 antigen. We ascertained significant elevation the beta subunit of hCG level in the group of women with neoplasms in comparison with control group (n = 96) and significant positive correlation between beta subunit level and degree of cancer cells maturity (r = 0.66, p < 0.05). We also ascertained strong positive correlation among beta subunit of hCG and CA 19-9 antigen level in the serum of the patients with vulval cancer (r = 0.55 and p < 0.05).
Piela
A
A
Oddziału Ginekologiczno-Połozniczego Wojewódzkiego Szpitala Specjalistycznego w Rzeszowie.
Lewandowska
M
M
D018394:CA-125 Antigen / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood*; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood / Q000175:diagnosis; D006801:Humans; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000097:blood / Q000175:diagnosis; D014846:Vulvar Neoplasms / Q000097:blood* / Q000175:diagnosis*
D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; D018997:Chorionic Gonadotropin, beta Subunit, Human